Manish A Shah Selected Research

Manish A Shah Research Topics

Disease

89	Neoplasms (Cancer) 10/2023 - 01/2003
43	Stomach Neoplasms (Stomach Cancer) 01/2022 - 05/2002
42	Adenocarcinoma 10/2023 - 11/2006
15	Disease Progression 01/2023 - 11/2006
11	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 05/2005
9	Neutropenia 01/2023 - 05/2005
8	Esophageal Neoplasms (Esophageal Cancer) 07/2022 - 07/2004
7	Pancreatic Neoplasms (Pancreatic Cancer) 10/2020 - 01/2009
6	Breast Neoplasms (Breast Cancer) 01/2023 - 11/2011
5	Neoplasm Metastasis (Metastasis) 01/2023 - 12/2011
5	Diarrhea 01/2023 - 05/2005
5	Carcinoma (Carcinomatosis) 10/2021 - 05/2002
5	Colonic Neoplasms (Colon Cancer) 01/2021 - 12/2013
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2022 - 04/2019
3	Esophageal Squamous Cell Carcinoma 01/2023 - 04/2019
3	Vomiting 01/2023 - 12/2009
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023 - 01/2014
3	Fatigue 10/2020 - 05/2005
3	Hypertension (High Blood Pressure) 01/2019 - 11/2006
3	Weight Loss (Weight Reduction) 12/2017 - 05/2013
2	Rectal Neoplasms (Rectal Cancer) 10/2023 - 01/2019
2	Nausea 01/2023 - 12/2009
2	Carcinogenesis 11/2022 - 12/2011
2	Hepatocellular Carcinoma (Hepatoma) 06/2021 - 04/2014
2	Circulating Neoplastic Cells 01/2021 - 01/2014
2	Microsatellite Instability 01/2020 - 01/2018
2	Turcot syndrome 01/2020 - 01/2018
2	Thrombosis (Thrombus) 03/2018 - 06/2012
2	Thrombocytopenia (Thrombopenia) 01/2017 - 12/2009
1	Abdominal Pain (Pain, Abdominal) 01/2023

Drug/Important Bio-Agent (IBA)

15	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 03/2005
14	pembrolizumabIBA 10/2023 - 01/2018
12	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2012
11	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 11/2006
10	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2023 - 12/2009
10	Irinotecan (Camptosar)FDA LinkGeneric 12/2020 - 04/2005
9	Monoclonal AntibodiesIBA 10/2023 - 05/2017
9	Trastuzumab (Herceptin)FDA Link 01/2023 - 12/2013
9	Bevacizumab (Avastin)FDA Link 06/2021 - 04/2005
7	Capecitabine (Xeloda)FDA Link 10/2023 - 10/2011
7	Leucovorin (Folinic Acid)FDA Link 01/2023 - 12/2009
6	Docetaxel (Taxotere)FDA Link 12/2020 - 01/2009
5	human ERBB2 proteinIBA 01/2023 - 11/2011
5	PlatinumIBA 10/2021 - 12/2009
5	Proteins (Proteins, Gene)FDA Link 01/2014 - 01/2008
4	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2019
4	NivolumabIBA 01/2023 - 06/2021
4	RNA (Ribonucleic Acid)IBA 10/2022 - 08/2009
4	Paclitaxel (Taxol)FDA LinkGeneric 07/2022 - 10/2008
4	RamucirumabIBA 02/2022 - 01/2014
4	andecaliximabIBA 12/2021 - 01/2018
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2021 - 06/2012
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 06/2010
4	taxaneIBA 01/2020 - 04/2012
4	alvocidib (flavopiridol)IBA 11/2010 - 05/2005
3	zolbetuximabIBA 10/2023 - 01/2023
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2021
3	pertuzumabIBA 01/2023 - 10/2018
3	GSK 1363089IBA 01/2022 - 01/2013
3	Taxoids (Taxanes)IBA 12/2021 - 01/2020
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2021 - 11/2020
3	Gemcitabine FDA Link 11/2020 - 09/2011
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 03/2005 - 01/2003
2	Immunoglobulin G (IgG)IBA 10/2023 - 11/2022
2	Protein Isoforms (Isoforms)IBA 01/2023 - 01/2023
2	napabucasinIBA 01/2023 - 07/2022
2	B7-H1 AntigenIBA 01/2023 - 10/2018
2	AntioxidantsIBA 01/2023 - 01/2021
2	AntibodiesIBA 11/2022 - 06/2010
2	LigandsIBA 10/2020 - 11/2014
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2020 - 01/2013
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 11/2019 - 01/2019
2	Ado-Trastuzumab EmtansineIBA 01/2019 - 01/2017
2	Cadherins (E-Cadherin)IBA 12/2017 - 01/2008
2	Immunoconjugates (Immunoconjugate)IBA 11/2017 - 09/2015
2	Epirubicin (Ellence)FDA LinkGeneric 06/2017 - 08/2016
2	onartuzumabIBA 05/2017 - 01/2016
2	AlbuminsIBA 01/2016 - 05/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2015 - 01/2013
2	Bortezomib (Velcade)FDA Link 06/2014 - 12/2011
2	Glucose (Dextrose)FDA LinkGeneric 11/2012 - 12/2011
2	ParaffinIBA 11/2011 - 01/2008
2	Protein Kinase CIBA 10/2008 - 03/2005
2	DNA (Deoxyribonucleic Acid)IBA 01/2008 - 12/2005
2	Cytotoxins (Cytolysins)IBA 08/2004 - 01/2003
1	ClaudinsIBA 10/2023
1	Complement System Proteins (Complement)IBA 10/2023
1	balstilimabIBA 10/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	IpilimumabIBA 01/2023
1	NAD (NADH)IBA 01/2023

Therapy/Procedure

55	Therapeutics 01/2023 - 05/2002
46	Drug Therapy (Chemotherapy) 10/2023 - 08/2004
8	Immunotherapy 10/2023 - 01/2019
6	Radiotherapy 01/2023 - 12/2011
5	Chemoradiotherapy 04/2021 - 05/2002
5	Neoadjuvant Therapy 01/2019 - 11/2012
3	Gastrectomy 01/2023 - 02/2013
3	Adjuvant Chemotherapy 03/2016 - 12/2011
2	Drug Tapering 01/2016 - 01/2009